The effect of high-dose methotrexate on renal tubules as indicated by urinary lysozyme concentration
- PMID: 7139568
- DOI: 10.1002/1097-0142(19821215)50:12<2775::aid-cncr2820501214>3.0.co;2-e
The effect of high-dose methotrexate on renal tubules as indicated by urinary lysozyme concentration
Abstract
Lysozyme was measured after 186 doses of methotrexate (MTX) to 88 patients. After 7.5% of the doses, lysozyme rose to between 2 and 19 micrograms/cc and in 3.2% it rose to between 20 and 120 micrograms/cc. These increases had no relationship to the age of the patients, their dose of MTX, the total number of times that MTX had been given, nor to rises in serum creatinine. It did correlate with the administration of aminoglycosides (a part of the supportive care of these patients) in two thirds of these cases. In patients who did not receive aminoglycosides, no urinary lysozyme concentration rose above 19 micrograms/cc, not even in the patients who became oliguric or required hemoperfusion. Most of these rises occurred early and were of 24 to 48 hour duration. The rises occurring after five days were persistent and were associated with prolonged MTX serum concentrations, suggesting that tubular damage due to MTX was the result of prolonged exposure to MTX, rather than the primary cause of kidney damage, i.e., the event causing the prolonged serum concentrations.
Similar articles
-
Renal tubular damage without glomerular damage after cytotoxic drugs and aminoglycosides.Biomedicine. 1980 Dec;33(8):251-4. Biomedicine. 1980. PMID: 7011432
-
High-dose methotrexate: on the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL).Cancer Chemother Pharmacol. 2003 Apr;51(4):311-20. doi: 10.1007/s00280-002-0552-1. Epub 2003 Mar 28. Cancer Chemother Pharmacol. 2003. PMID: 12721759
-
Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function.Med Pediatr Oncol. 2003 Jun;40(6):348-54. doi: 10.1002/mpo.10293. Med Pediatr Oncol. 2003. PMID: 12692801
-
[Renal tubular dysfunction in patients with rheumatoid arthritis starting with low dose of methotrexate].Pol Arch Med Wewn. 2003 Aug;110(2):855-62. Pol Arch Med Wewn. 2003. PMID: 14682224 Polish.
-
What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning?Clin Toxicol (Phila). 2017 Feb;55(2):88-96. doi: 10.1080/15563650.2016.1271126. Clin Toxicol (Phila). 2017. PMID: 28084171 Review.
Cited by
-
The effects of diltiazem on methotrexate-induced nephrotoxicity.Eur J Clin Pharmacol. 1989;37(4):337-40. doi: 10.1007/BF00558496. Eur J Clin Pharmacol. 1989. PMID: 2689182 Clinical Trial.
-
High-dose 7-hydromethotrexate: acute toxicity and lethality in a rat model.Cancer Chemother Pharmacol. 1996;37(5):415-22. doi: 10.1007/s002800050406. Cancer Chemother Pharmacol. 1996. PMID: 8599863
-
Survival after unexpected high serum methotrexate concentrations in a patient with osteogenic sarcoma.Drug Saf. 1990 Nov-Dec;5(6):447-54. doi: 10.2165/00002018-199005060-00005. Drug Saf. 1990. PMID: 2285498
-
Renal and hepatic toxicity after high-dose 7-hydroxymethotrexate in the rat.Cancer Chemother Pharmacol. 1994;34(2):119-24. doi: 10.1007/BF00685928. Cancer Chemother Pharmacol. 1994. PMID: 8194163
-
Renal impairment following the combined use of high-dose methotrexate and procarbazine.Cancer Chemother Pharmacol. 1988;21(3):265-7. doi: 10.1007/BF00262783. Cancer Chemother Pharmacol. 1988. PMID: 3359561